Canaan Partners
No summary available yet.
Canaan is a solid, if unremarkable, mid-tier fund that does exactly what it says on the tin. They're not chasing the hottest trends or making splashy bets, which can actually be refreshing. Their partners have genuine operating experience and won't waste your time with MBA-speak. The downside? They can be painfully slow to move and their brand doesn't open as many doors as the tier-one funds. They're the reliable Honda Civic of VC - not sexy, but they'll get you where you need to go without breaking down.
- —Best for: B2B SaaS founders who want experienced operators as investors
- —Watch out for: Slow decision-making process and limited brand recognition
- —Known for: Steady, methodical approach and strong post-investment support
Canaan invests in early-stage B2B software, fintech, and healthcare companies that can scale globally. They focus on founders building category-defining businesses with strong unit economics and defensible moats.
Series A to Series C focused, with occasional seed investments. Heavy emphasis on B2B SaaS, fintech infrastructure, and healthcare tech. Portfolio skews toward enterprise software with recurring revenue models.
Former enterprise software exec who joined Canaan in 2002. Known for B2B investments and strong operator background. Founders appreciate her hands-on approach and deep enterprise sales knowledge.
Joined from Shasta Ventures, focuses on B2B software and fintech. Former McKinsey consultant with strong analytical approach. Reputation for being thorough but sometimes slow to decision.
Healthcare and life sciences specialist who joined in 2015. Former biotech entrepreneur and consultant. Well-regarded in the healthtech community for his scientific background and network.
Have a specific question about Canaan Partners?
Ask Bernie →